Disclosure Quest - Search SEC Filings

Name	Type of Offering	Accepted Date
AsclepiX Therapeutics, Inc. See All Filings	D	2024-04-26 13:07:32 UTC
Amount To Be Raised $12,544,498 Associated Brokers / Dealers N/A CIK Number 0001697751 Filed Document 0001697751-24-000003 Exclusions or Exemptions 506b Accepted Date 2024-04-26 13:07:32 UTC Type of Offering D Industry Biotechnology Principal Place of Business MARYLAND Revenue or Assets Decline to Disclose Type of Security Equity
AsclepiX Therapeutics, Inc. See All Filings	D	2020-06-11 11:36:40 UTC
Amount To Be Raised $35,000,000 Associated Brokers / Dealers N/A CIK Number 0001697751 Filed Document 0001697751-20-000001 Exclusions or Exemptions 506b Accepted Date 2020-06-11 11:36:40 UTC Type of Offering D Industry Biotechnology Principal Place of Business MARYLAND Revenue or Assets Decline to Disclose Type of Security Equity
AsclepiX Therapeutics, Inc. See All Filings	D/A	2019-06-17 16:41:02 UTC
Amount To Be Raised $10,000,000 Associated Brokers / Dealers Solebury Capital LLC CIK Number 0001697751 Filed Document 0001697751-19-000001 Exclusions or Exemptions 506b Accepted Date 2019-06-17 16:41:02 UTC Type of Offering D/A Industry Biotechnology Principal Place of Business MARYLAND Revenue or Assets Decline to Disclose Type of Security Debt
AsclepiX Therapeutics, Inc. See All Filings	D	2018-10-25 16:36:07 UTC
Amount To Be Raised $7,500,000 Associated Brokers / Dealers Solebury Capital LLC CIK Number 0001697751 Filed Document 0001697751-18-000004 Exclusions or Exemptions 506b Accepted Date 2018-10-25 16:36:07 UTC Type of Offering D Industry Biotechnology Principal Place of Business MARYLAND Revenue or Assets Decline to Disclose Type of Security Debt
AsclepiX Therapeutics, LLC See All Filings	D	2017-02-09 16:18:21 UTC
Amount To Be Raised $1,000,000 Associated Brokers / Dealers N/A CIK Number 0001697751 Filed Document 0001697751-17-000001 Exclusions or Exemptions 506b Accepted Date 2017-02-09 16:18:21 UTC Type of Offering D Industry Biotechnology Principal Place of Business MARYLAND Revenue or Assets Decline to Disclose Type of Security Debt